Prostatic artery embolization for intractable hematuria in patients with unregulated coagulation parameters: three case reports
https://doi.org/10.4081/aiua.2024.12306
Accepted: February 9, 2024
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Introduction: Benign prostatic hyperplasia is a prevalent disease that could be responsible of severe intractable hematuria requiring invasive surgical management.
Case presentation: We report three high-risk cases presented with intractable hematuria of prostatic origin with high medical co-morbidities treated safely and effectively by prostatic artery embolization with favorable outcomes.
Conclusions: In non-surgical, anticoagulated patients, prostatic artery embolization represents a safe and effective intervention for the treatment of intractable hematuria related to benign prostatic hyperplasia.
Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol. 1984; 132:474-9. DOI: https://doi.org/10.1016/S0022-5347(17)49698-4
Ramyil VM, Dakum NK, Liman HU, Udeh EI. The management of prostatic haematuria. Niger J Med. 2008; 17:439-42. DOI: https://doi.org/10.4314/njm.v17i4.37429
Elzayat EA, Elhilali MM. Holmium laser enucleation of the prostate (HoLEP): the endourologic alternative to open prostatectomy. Eur Urol. 2006; 49:87-91. DOI: https://doi.org/10.1016/j.eururo.2005.08.015
Elzayat E, Habib E, Elhilali M. Holmium laser enucleation of the prostate in patients on anticoagulant therapy or with bleeding disorders. J Urol. 2006; 175:1428-32. DOI: https://doi.org/10.1016/S0022-5347(05)00645-2
DeMeritt JS, Elmasri FF, Esposito MP, Rosenberg GS. Relief of benign prostatic hyperplasia-related bladder outlet obstruction after transarterial polyvinyl alcohol prostate embolization. J Vasc Interv Radiol. 2000; 11:767-70. DOI: https://doi.org/10.1016/S1051-0443(07)61638-8
Kuang M, Vu A, Athreya S. A Systematic Review of Prostatic Artery Embolization in the Treatment of Symptomatic Benign Prostatic Hyperplasia. Cardiovasc Intervent Radiol. 2017; 40:655-663. DOI: https://doi.org/10.1007/s00270-016-1539-3
Tian W, Zhou C, Leng B, et al. Prostatic Artery Embolization for Control of Gross Hematuria in Patients with Benign Prostatic Hyperplasia: A Single-Center Retrospective Study in 20 Patients. J Vasc Interv Radiol. 2019; 30:661-667. DOI: https://doi.org/10.1016/j.jvir.2019.02.008
Mohan S, Kumar S, Dubey D, et al. Superselective vesical artery embolization in the management of intractable hematuria secondary to hemorrhagic cystitis. World J Urol. 2019; 37:2175-2182. DOI: https://doi.org/10.1007/s00345-018-2604-0
Kearney MC, Bingham J, Bergland R, et al. Clinical predictors in the use of finasteride for control of gross hematuria due to benign prostatic hyperplasia. J Urol. 2002; 167:2489-2491. DOI: https://doi.org/10.1016/S0022-5347(05)65011-2
Hanson RA, Zornow MH, Conlin MJ, Brambrink AM. Laser resection of the prostate: implications for anesthesia. Anesth Analg. 2007; 105:475-9. DOI: https://doi.org/10.1213/01.ane.0000270217.82825.1f
Feng S, Tian Y, Liu W, et al. Prostatic Arterial Embolization Treating Moderate-to-Severe Lower Urinary Tract Symptoms Related to Benign Prostate Hyperplasia: A Meta-Analysis. Cardiovasc Intervent Radiol. 2017; 40:22-32. DOI: https://doi.org/10.1007/s00270-016-1516-x
Abt D, Hechelhammer L, Müllhaupt G, et al. Comparison of prostatic artery embolisation (PAE) versus transurethral resection of the prostate (TURP) for benign prostatic hyperplasia: randomised, open label, non-inferiority trial. BMJ. 2018; 361:k2338. DOI: https://doi.org/10.1136/bmj.k2338
Carnevale FC, Moreira AM, Antunes AA. The "PErFecTED technique": proximal embolization first, then embolize distal for benign prostatic hyperplasia. Cardiovasc Intervent Radiol. 2014; 37:1602-5. DOI: https://doi.org/10.1007/s00270-014-0908-z
Copyright (c) 2024 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Downloads
Citations
